Zobrazeno 1 - 7
of 7
pro vyhledávání: '"PAVEL POTUZNIK"'
Autor:
Pavel Potuznik, Jiri Drahota, Dana Horakova, Marek Peterka, Aneta Mazouchova, David Matyas, Zbysek Pavelek, Marta Vachova, Eva Recmanova, Ivana Stetkarova, Jana Libertinova, Jan Mares, Pavel Stourac, Marketa Grunermelova, Alena Martinkova, Jana Adamkova, Pavel Hradilek, Radek Ampapa, Michal Dufek, Eva Kubala Havrdova, Dominika Stastna
Publikováno v:
Journal of Central Nervous System Disease, Vol 16 (2024)
Background Cladribine, a selective immune reconstitution therapy, is approved for the treatment of adult patients with highly active multiple sclerosis (MS). Objectives Provide experience with cladribine therapy in a real-world setting. Methods This
Externí odkaz:
https://doaj.org/article/184f4c6999bb4bada8b072f3e0cb99d2
Publikováno v:
Biomedical Papers, Vol 167, Iss 2, Pp 192-198 (2023)
Objective. The aim of the study was to investigate the associations of cross-sectional area (CSA) of the median nerve measured by ultrasonography, the median to ulnar nerve ratio (MUR), the median to ulnar nerve difference (MUD) and the ratio of CSA
Externí odkaz:
https://doaj.org/article/c579550dcb4f4c8b9dc77e510c671028
Autor:
Martina Kropp, Olga Golubnitschaja, Alena Mazurakova, Lenka Koklesova, Nafiseh Sargheini, Trong-Tin Kevin Steve Vo, Eline de Clerck, Jiri Polivka, Pavel Potuznik, Ivana Stetkarova, Peter Kubatka, Gabriele Thumann
Publikováno v:
EPMA Journal. 14:21-42
Proliferative diabetic retinopathy (PDR) the sequel of diabetic retinopathy (DR), a frequent complication of diabetes mellitus (DM), is the leading cause of blindness in the working-age population. The current screening process for the DR risk is not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::141ea9937413bd5fc258bb1c0f0fd74b
https://doi.org/10.1007/s13167-023-00314-8
https://doi.org/10.1007/s13167-023-00314-8
Autor:
Olga Golubnitschaja, Pavel Potuznik, Jiri Polivka, Martin Pesta, Olga Kaverina, Claus C. Pieper, Martina Kropp, Gabriele Thumann, Carl Erb, Alexander Karabatsiakis, Ivana Stetkarova, Vincenzo Costigliola
Publikováno v:
The EPMA journal. 13(4)
Due to the reactive medical approach applied to disease management, stroke has reached an epidemic scale worldwide. In 2019, the global stroke prevalence was 101.5 million people, wherefrom 77.2 million (about 76%) suffered from ischemic stroke; 20.7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99881b2d2407e376363086f0a093f14e
https://pubmed.ncbi.nlm.nih.gov/36415625
https://pubmed.ncbi.nlm.nih.gov/36415625
Publikováno v:
Biomedical Papers.
The aim of the study was to investigate the associations of cross-sectional area (CSA) of the median nerve measured by ultrasonography, the median to ulnar nerve ratio (MUR), the median to ulnar nerve difference (MUD) and the ratio of CSA of the medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b00a92a8055275d70365548b8a91b24f
https://doi.org/10.5507/bp.2021.068
https://doi.org/10.5507/bp.2021.068
Autor:
JIRI POLIVKA, MARIAN SVAJDLER, VLADIMIR PRIBAN, JAN MRACEK, PETR KASIK, PETR MARTINEK, NIKOLA PTAKOVA, MAHYAR SHARIF BAGHERI, DATTATRYA SHETTI, MARTIN PESTA, PAVEL POTUZNIK, ONDREJ TOPOLCAN
Publikováno v:
Anticancer research. 42(4)
Gliomas are primary malignancies of the central nervous system (CNS). High-grade gliomas are associated with poor prognosis and modest survival rates despite intensive multimodal treatment strategies. Targeting gene fusions is an emerging therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8ea9901968e7f97e675e7de1dfad8a8
https://pubmed.ncbi.nlm.nih.gov/35347013
https://pubmed.ncbi.nlm.nih.gov/35347013
Autor:
Zbyšek Pavelek, Lukáš Sobíšek, Jana Šarláková, Pavel Potužník, Marek Peterka, Ivana Štětkárová, Pavel Štourač, Jan Mareš, Pavel Hradílek, Radek Ampapa, Markéta Grünermelová, Marta Vachová, Eva Recmanová, Francesco Angelucci, Simona Halúsková, Martin Vališ
Publikováno v:
Frontiers in Neurology, Vol 11 (2021)
Background: Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system. Well-established drugs used for MS patients after the first demyelinating event in the Czech Republic include glatiramer acetat
Externí odkaz:
https://doaj.org/article/d363f0282e7041f3a3b4674b61fb53d7